ProCE Banner Activity

Call to Action: What to Know About Caring for Adult and Pediatric Patients With Inoperable Neurofibromatosis Type 1-Associated Tumors

Clinical Thought

This expert commentary dicusses key concepts in the care of patients with tumors associated with neurofibromatosis type 1, including plexiform neurofibromas and optic gliomas.

Released: October 09, 2023

Share

Faculty

Jaishri Blakeley

Jaishri Blakeley, MD

The Marjorie Bloomberg Tiven Professor of Neurofibromatosis
Director, The Neurofibromatosis Therapeutic Acceleration Program
Director, The Johns Hopkins Comprehensive Neurofibromatosis Program
Department of Neurology, Neruo-Oncology
The Johns Hopkins School of Medicine
Baltimore, Maryland

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This activity is supported by an educational grant from Alexion Pharmaceuticals.

Alexion Pharmaceuticals

Faculty Disclosure

Primary Author

Jaishri Blakeley, MD

The Marjorie Bloomberg Tiven Professor of Neurofibromatosis
Director, The Neurofibromatosis Therapeutic Acceleration Program
Director, The Johns Hopkins Comprehensive Neurofibromatosis Program
Department of Neurology, Neruo-Oncology
The Johns Hopkins School of Medicine
Baltimore, Maryland

Jaishri Blakeley, MD, FAAN: consultant/advisor/speaker: SpringWorks Therapeutics.